Werewolf Therapeutics Appoints Tim Trost as Chief Financial Officer
Veteran life sciences financial executive brings over 25 years finance and capital markets expertise
News provided by
Share this article
Share this article
CAMBRIDGE, Mass., Feb. 8, 2021 /PRNewswire/ Werewolf Therapeutics, Inc., an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body s immune system for the treatment of cancer, today announced the appointment of Tim Trost as Chief Financial Officer (CFO). Mr. Trost is an accomplished life sciences executive with extensive leadership experience in financial and accounting operations and strategy. I am thrilled to welcome Tim to the Werewolf team, said Daniel J. Hicklin, Ph.D., Founder and Chief Executive Officer of Werewolf Therapeutics. Tim brings extensive experience in leading and guiding life sciences companies through different stages of development. His expertise a
Cal Poly faculty member Anahid Behrouzi (left) in the Concrete Lab as students measure aggregates for use in a concrete mix as part of the Reinforced Concrete Design course. Image credit: Cal Poly CAED/Josef Kasperovich.
–A Cal Poly architectural engineering faculty member was honored for excellence and innovation in teaching by the American Concrete Institute (ACI), a leading professional organization in the global concrete industry.
Anahid Behrouzi is the 2021 recipient of the ACI Walter P. Moore Jr. Faculty Achievement Award, which recognizes new faculty members for how they teach concrete design, materials, or construction. She has been at Cal Poly since 2016. The ACI Board of Direction bestowed the honor specifically “for blending new technologies, hands-on experiences, and storytelling to motivate students and to make concrete design concepts tangible.”
ELYSSA CHERNEY
Chicago Tribune
Bonnie Laughlin-Schultz enforces social distancing, sanitizes surfaces and keeps a face shield for emergencies this semester as she convenes in-person classes at Eastern Illinois University.
The associate professor decided to work in the classroom to help her students after nearly a year of online learning, but she worries about bringing COVID-19 home and infecting others in Charleston. As an extra precaution, Laughlin-Schultz said she tried wearing two masks during the 75-minute sessions, but that muffled her voice during lectures.
âI am very conscious of safety and of my studentsâ safety,â said Laughlin-Schultz, 45. âI donât want anyone anywhere near me because I donât want to be infected or to infect any of them.â
Feb 8, 2021
MONDAY, Feb. 8, 2021 (HealthDay News) Medicaid expansions are associated with increases in the percentage of people living with HIV who are aware of their status and with greater use of preexposure prophylaxis, according to a study published online Jan. 24 in the
American Journal of Preventive Medicine.
Bita Fayaz Farkhad, Ph.D., from the University of Illinois at Urbana-Champaign, and colleagues estimated the effects of the Medicaid expansions using data on HIV diagnoses per 100,000 population, awareness of HIV status, and preexposure prophylaxis use. The analysis compared data before and after the expansions, as well as differences between treatment counties (all counties in states that expanded Medicaid) and control counties (all counties in states that did not expand Medicaid).